Essential cookies only by default. Analytics and error replays need your OK.
Vitamin K2 (Menaquinone)
Fat-soluble vitamin that activates calcium-binding proteins in bone and blood vessels. Supplements raise these markers, but benefits for bone density and arteries are not established.
What the evidence says
Vitamin K2 doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 1990–2026 with a typical study size of 132 participants.
Based on 118 studies · 16 meta-analyses · 78 RCTs · 243,102 total participants · 4 retracted studies left out
Study base
Strong study baseWhat the studies found
By outcome
Every outcome below: Too few graded studies.
K2 reliably raises carboxylated osteocalcin and matrix Gla protein, but that has not translated into consistent clinical benefit. A 2019 meta-analysis found no effect on bone density or vertebral fractures after menopause, MK-7 trials disagree, the fracture data rest on Japanese MK-4 at a drug dose, and calcification trials are mostly null.
74 randomised trials
86% were about Vitamin K2 in an audit of 50 of them
Every randomised or controlled trial of Vitamin K2 indexed in PubMed, not a hand-picked subset. Meta-analyses and systematic reviews are deliberately excluded from this count: most of them cover many compounds at once, so counting them would inflate it.
PubMed · as of Sep 2026
13 trials ongoing or recruiting · 60 completed on ClinicalTrials.gov
3 of the completed trials have posted results
Registered trials show research momentum for Vitamin K2, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Under EU law (Reg. 1924/2006), EFSA reviews whether a specific health claim for Vitamin K2 meets the evidence standard. These are independent regulatory decisions on claims — not studies, and never counted toward the evidence score above.
“Not authorised” means the specific claim wording did not meet the EU’s evidence standard — often a matter of dossier or phrasing, not proof of no effect. EFSA judges marketing claims and is kept separate from our study-based evidence score.
Source: EU Register of nutrition and health claims (European Commission / EFSA) · register snapshot Feb 2013
Vitamin K2 (menaquinone) is the cofactor that activates osteocalcin in bone and matrix Gla protein in blood vessels, and supplements reliably raise the activated forms. Whether that leads to stronger bones or healthier arteries is not settled.
Some MK-7 trials slowed bone loss after menopause and others did not, the Japanese fracture data come from MK-4 at 45 mg a day, a prescription drug dose, and trials on arterial and valve calcification have mostly found no effect. MK-7 is the form most supplements use.
Carboxylates osteocalcin, a bone protein that binds calcium. Supplements move this marker, but a bone density gain does not reliably follow
Carboxylates matrix Gla protein, an inhibitor of calcification in blood vessels. Supplements raise the active form, but trials have not shown that arteries calcify less
How Vitamin K2 works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Adequate safety data in pregnancy and breastfeeding are lacking: no trial has tested vitamin K2 supplements for any pregnancy outcome.
On warfarin (Coumadin), phenprocoumon (Marcoumar), acenocoumarol or another vitamin-K antagonist: vitamin K2 directly opposes the drug's mechanism and can lower the INR, raising clot risk — do not start, stop or change the dose without your prescriber, keep intake consistent and monitor INR. On a DOAC (apixaban, rivaroxaban, dabigatran, edoxaban) or a heparin (including enoxaparin): these act on factor Xa, thrombin or antithrombin, not through vitamin K, so vitamin K2 intake does not change their effect.
Vitamin K2 promotes clotting factors that warfarin is designed to inhibit. Taking K2 can significantly reduce anticoagulant effectiveness, increasing risk of dangerous blood clots. Requires medical supervision and INR monitoring if used together.
This pair has not been assessed from the evidence supplied. These medicines act on factor Xa, thrombin or antithrombin and are not vitamin K antagonists like warfarin, so INR-style vitamin K monitoring does not apply to them. Mention the supplement to the prescriber, as with any supplement.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: N/A
Vitamin K2 has an evidence score of 5/10 — moderate evidence based on 118 indexed studies, including 10 meta-analyses. Fat-soluble vitamin that activates calcium-binding proteins in bone and blood vessels. Supplements raise these markers, but benefits for bone density and arteries are not established. Representative study: PMID 41268154.
The best time to take Vitamin K2 is with meals. Take it with food. Vitamin K2 (menaquinone) is fat-soluble and the cofactor that activates matrix Gla protein and osteocalcin.
Vitamin K2 has a safety rating of "moderate". That is a category, not a measure of individual risk, and there are precautions worth knowing. Reported side effects include none commonly reported. How often they occur is not established for all of them. Use caution if any of these apply to you: Those taking warfarin or other vitamin K antagonists (consult doctor); Vitamin-K-antagonist anticoagulants — warfarin (Coumadin), phenprocoumon (Marcoumar), acenocoumarol — because vitamin K2 directly opposes their mechanism; keep intake consistent and monitor INR rather than starting or stopping abruptly. DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) and heparins do not depend on vitamin K and are not affected by vitamin K2 intake.
Vitamin D3
MixedHormone-like vitamin that regulates 1,000+ genes — deficiency is widespread and linked to poor immunity, depression, and bone loss.
Vitamin B12
HelpedDrives nerve myelination, red blood cell formation, and DNA synthesis — deficiency is common in vegans, vegetarians, and older adults.
Vitamin B6
HelpedCofactor in 100+ enzyme reactions including serotonin, dopamine, and GABA synthesis — also lowers homocysteine levels.
Multivitamin
Too few graded studiesNutritional insurance that fills micronutrient gaps. In the large COSMOS trial, a daily multivitamin improved memory and slowed cognitive decline in older adults — but it did not reduce total cancer, cardiovascular disease, or mortality.
Supplement–Drug Interactions
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
Perimenopause & Menopause
Hot flashes, bone, sleep, muscle — the basics that hold up vs the phytoestrogen hype.
Vitamin D: The Complete Guide
Worth it if you’re deficient (and many are) — dosing, testing, D3 vs D2, and the K2 question.
Supplement Timing & Combining
When to take what, with or without food, and which supplements compete vs pair well.
Explore: Best supplements for Vitality & LongevityBest supplements for Women's HealthBest supplements for Body Health
Reviewed by Dr. Baher Al Hakim · Last reviewed October 2026 · evidence from 122 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research